Moreira-Gonzalez Andrea, Jackson Ian T, Miyawaki Takeshi, DiNick Vincent, Yavuzer Reha
Institute for Craniofacial and Reconstructive Surgery, Mich. 49075, USA.
Plast Reconstr Surg. 2003 May;111(6):1808-17. doi: 10.1097/01.PRS.0000055432.20074.93.
Augmentation of the craniomaxillofacial region is required for many aesthetic and reconstructive procedures. A variety of different materials and techniques have been used. Coralline hydroxyapatite has proved to have biocompatible properties as a bone graft substitute. This study further analyzes the use of porous coral-derived hydroxyapatite granules in craniomaxillofacial augmentation for cosmetic and reconstructive purposes and evaluates the long-term clinical result. This retrospective study reviewed the use of porous coral-derived hydroxyapatite granules over a 20-year period, between 1981 and 2001, in 180 patients, in whom 393 procedures were performed. The surgical technique is described and discussed. Statistical significance was evaluated by descriptive statistics and the correlation bivariate Spearman's test (p > 0.05). For 61.6 percent of the procedures, the surgical indication was reconstructive and in 38.4 percent, cosmetic. The maxilla was the most common site of surgery (44.3 percent), followed by the mandible (21.6 percent) and zygoma (15.4 percent). The complication rate was 5.6 percent (n = 22 of 393), with contour irregularities being responsible for 59 percent (n = 13 of 22). Both infection and granule extrusion were responsible for 1.3 percent of the complications. Good results were achieved in 96.4 percent of the procedures. Porous coral-derived hydroxyapatite granules have shown considerable efficacy and versatility in craniofacial contour refinement and augmentation. They are stable, biocompatible, and safe. A sterile technique is advised, with care taken not to tear the periosteum in the pocket design and with subperiosteal placement of the granules, compaction of the granules at the site, overcorrection of 15 percent of the required total volume, watertight closure, and postoperative taping to prevent mobilization. The correct surgical indications and adherence to the principles stated above will result in a very satisfactory long-term outcome.
许多美容和重建手术都需要对颅颌面区域进行增大。人们已经使用了各种不同的材料和技术。珊瑚羟基磷灰石已被证明作为骨移植替代物具有生物相容性。本研究进一步分析了多孔珊瑚衍生羟基磷灰石颗粒在颅颌面增大美容和重建目的中的应用,并评估长期临床结果。这项回顾性研究回顾了1981年至2001年20年间在180例患者中使用多孔珊瑚衍生羟基磷灰石颗粒的情况,共进行了393例手术。描述并讨论了手术技术。通过描述性统计和双变量Spearman相关性检验评估统计学意义(p>0.05)。61.6%的手术适应证为重建,38.4%为美容。上颌是最常见的手术部位(44.3%),其次是下颌(21.6%)和颧骨(15.4%)。并发症发生率为5.6%(393例中有22例),其中轮廓不规则占59%(22例中有13例)。感染和颗粒挤出均占并发症的1.3%。96.4%的手术取得了良好效果。多孔珊瑚衍生羟基磷灰石颗粒在颅面轮廓改善和增大方面显示出相当的疗效和多功能性。它们稳定、生物相容且安全。建议采用无菌技术,在腔隙设计中小心不要撕裂骨膜,颗粒进行骨膜下放置,在部位压实颗粒,对所需总体积进行15%的过度矫正,严密缝合,并术后包扎以防止移动。正确的手术适应证和遵循上述原则将产生非常令人满意的长期结果。